Counterfeit drugs pose a significant threat to public health and safety, requiring innovative and effective solutions to combat this global problem.

In November, the Department of Pharmaceuticals took a crucial step towards addressing this issue by publishing a gazette notice. According to this notice, starting on August 1, 2023, the 300 most popular formulation brands will be required to incorporate a barcode or quick response (QR) code on their labels.